Early and Long-term Results of ePTFE (Gore TAG®) versus Dacron (Relay Plus® Bolton) Grafts in Thoracic Endovascular Aneurysm Repair

Mezzetto, Luca; Scorsone, Lorenzo; Silingardi, Roberto; Gennai, Stefano; Leone, Nicola; Piffaretti, Gabriele; Veraldi, Gian Franco

doi:10.1016/j.avsg.2020.07.054

Cited by 16 publications

(11 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The currently available stent graft systems are made of different materials. Mezzetto et al [20] compared early and late results of an expanded polytetrafluoroethylene (ePTFE Gore TAG, Gore Medical, Flagstaff, AZ, US) mesh-structured stent graft to a Dacron one (Relay Plus, Terumo Medical, Tokyo, Japan, Figure 3) for TEVAR in 129 consecutive patients in both elective and emergency settings. Technical success was achieved in 100%, of which 22.4% were emergency procedures.…”

Section: Current Tevar Platformsmentioning

confidence: 99%

Thoracic endovascular aortic repair: Current evidence and challenges

Juraszek¹,

Czerny²,

Rylski³

2022

Kardiol Pol

View full text Add to dashboard Cite

In 1987 Nikolay Volodos performed the world's first endovascular treatment of aortic aneurysms. Endovascular technology has progressed significantly since then. There are now many thoracic endovascular aortic repair (TEVAR) systems commercially available. By applying them, we can treat many pathologies: aneurysms, dissections, aortic ruptures, and penetrating aortic ulcers. However, TEVAR technology still has its limitations, namely the risk of a retrograde type A dissection, the issue of precise landing in the distal landing zone, and the risk of air embolism and paraplegia. Furthermore, there are no appropriate stent grafts widely available to treat acute dissections. Those currently used are designed for aneurysms, not for dissections. As a result, there are several challenges facing the future TEVAR surgical community, such as the need to develop new and more precise systems with retrograde deployment for the distal landing zone, as well as to introduce flexible stent grafts to treat dissections. The endo-Bentall is being developed as an alternative treatment method for acute type-A aortic dissection.

show abstract

Section: Current Tevar Platformsmentioning

confidence: 99%

Thoracic endovascular aortic repair: Current evidence and challenges

Juraszek¹,

Czerny²,

Rylski³

2022

Kardiol Pol

View full text Add to dashboard Cite

show abstract

“…In a recent prospective database study, ePTFE (Gore TAG®) and Dacron (Relay Plus® Bolton) device for TEVAR were compared in term of early and late outcomes 45 . 56 patients were part of the ePTFE group (group A) and 73 of the Dacron group (group B).…”

Section: Clinical Trial Of Eptfe Medical Devicesmentioning

confidence: 99%

ePTFE‐based biomedical devices: An overview of surgical efficiency

et al. 2021

View full text Add to dashboard Cite

Polytetrafluoroethylene (PTFE) is a ubiquitous material used for implants and medical devices in general because of its high biocompatibility and inertness: blood vessel, heart, table jawbone, nose, eyes, or abdominal wall can benefit from its properties in case of disease or injury. Its expanded version, ePTFE is an improved version of PTFE with better mechanical properties, which extends its medical applications. A material as frequently used as ePTFE with these exceptional properties deserves a review of its main uses, developments, and possibility of improvements. In this systematic review, we examined clinical trials related to ePTFE‐based medical devices from the literature. Then, we excluded all trials using ePTFE as a control to test other devices. ePTFE‐coated stents, hemodialysis and bypass grafts, guided bone and tissue regeneration membranes, hernia and heart repair and other devices are reviewed. The rates of success using these devices and their efficiency compared to other materials used for the same purposes are reported. ePTFE appears to be more or just as efficient compared to them. Some success rates remain low, suggesting the need of improvement ePTFE for medical applications.

show abstract

“…Several meta-analyses and large registry studies have suggested that women may be treated differently and are at higher risk of peri-operative mortality and morbidity following vascular interventions in the aorta and peripheral arteries [4][5][6]. Thoracic endovascular aortic repair (TEVAR) has become a well-established alternative to treat aortic diseases including descending thoracic aortic aneurysm (TAA), complicated type B aortic dissection or traumatic aortic injury [7][8][9][10][11][12]. This minimally invasive technique can be used to treat intact and ruptured TAA (iTAA/rTAAA), offering repair to patients unfit or at high risk for traditional open surgery [13][14][15][16][17], whilst also minimizing risks of stroke and paraplegia [8,18].…”

Section: Introductionmentioning

confidence: 99%

Impact of Female Sex on Outcomes of Patients Undergoing Thoracic Endovascular Aortic Aneurysm Repair: A Ten-Year Retrospective Nationwide Study in France

Lareyre

Raffort

Behrendt

et al. 2022

JCM

View full text Add to dashboard Cite

The impact of sex on the outcomes of patients with cardiovascular disease is still incompletely understood. The aim of this nationwide multicenter observational study was to investigate the impact of sex on post-operative outcomes in patients undergoing thoracic endovascular aortic repair (TEVAR) for intact thoracic aortic aneurysm (iTAA). The French National Health Insurance Information System was searched to identify these patients over a ten-year retrospective period. Post-operative outcomes, 30-day and overall mortality were recorded. Among the 7383 patients included (5521 men and 1862 women), females were significantly older than males (66.8 vs. 64.8 years, p < 0.001). They were less frequently diagnosed with cardiovascular comorbidities. Post-operatively, women had less frequently respiratory (10.9 vs. 13.7%, p = 0.002) as well as cardiac complications (34.3 vs. 37.3%, p = 0.023), but they had more frequently arterial complications (52.8 vs. 49.8%, p = 0.024). There was no significant difference on overall mortality for a mean follow-up of 2.2 years (26.9 vs. 27.6%, p = 0.58). In the multivariable regression model, female sex was not associated with 30-day or overall mortality. Although women had a favorable comorbidity profile, the short-term and long-term survival was similar. The significantly higher rate of arterial complications suggests that women may be at higher risk of access-vessel-related complications.

show abstract

Early and Long-term Results of ePTFE (Gore TAG®) versus Dacron (Relay Plus® Bolton) Grafts in Thoracic Endovascular Aneurysm Repair

Cited by 16 publications

References 34 publications

Thoracic endovascular aortic repair: Current evidence and challenges

Thoracic endovascular aortic repair: Current evidence and challenges

ePTFE‐based biomedical devices: An overview of surgical efficiency

Impact of Female Sex on Outcomes of Patients Undergoing Thoracic Endovascular Aortic Aneurysm Repair: A Ten-Year Retrospective Nationwide Study in France

Contact Info

Product

Resources

About